A5052103501- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Esophageal and GI Pathology
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Helicobacter pylori-related gastroenterology studies
- Multiple and Secondary Primary Cancers
- Cancer Risks and Factors
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- RNA modifications and cancer
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gut microbiota and health
- Acute Lymphoblastic Leukemia research
- Nutritional Studies and Diet
- Cancer-related molecular mechanisms research
- Childhood Cancer Survivors' Quality of Life
- Cancer-related gene regulation
- Air Quality and Health Impacts
- Economic and Financial Impacts of Cancer
- Healthcare Systems and Public Health
- Liver Disease Diagnosis and Treatment
- MicroRNA in disease regulation
- Cervical Cancer and HPV Research
Chinese Academy of Medical Sciences & Peking Union Medical College
2016-2025
Henan University
2025
Sun Yat-sen University
2024
Nanjing Medical University
2023-2024
Beijing Technology and Business University
2022-2024
Changhai Hospital
2023
Second Military Medical University
2023
Peking Union Medical College Hospital
2020-2023
Baoshan College
2023
National Clinical Research
2022
National Cancer Center (NCC) of China annually reports the nationwide statistics for cancer incidence and mortality using population-based registry data from all available registries in China.
Abstract Background Breast cancer is the most commonly diagnosed and leading cause of death among women worldwide but has patterns trends which vary in different countries. This study aimed to evaluate global breast incidence mortality analyze its temporal for prevention control. Methods data 2020 were obtained from GLOBOCAN online database. Continued Cancer Incidence Five Continents Time Trends, International Agency Research on China National Central Registry used time 2000 2015 through...
The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. International Agency for Research (IARC) calculates publishes burden countries around world every two years. To ensure consistency between actual surveillance data published by IARC, NCC has received approval from Health Commission IARC to simultaneously release GLOBOCAN 2022. There were a total 700 registries reporting high-quality across 2018, which 106 with...
Objective: Data from local cancer registries were pooled to estimate incidence and mortality in China, 2015. Methods: submitted 501 checked & evaluated according the criteria of data quality control, 368 registries' qualified for final analysis. stratified by area (urban/rural), sex, age group sites, combined with national population Chinese census 2000 Segi's used age-standardized. Results: Total covered 309 553 499 (148 804 626 urban 160 748 873 rural areas). The percentage morphologically...
National Cancer Center (NCC) updated nationwide cancer statistics using population-based registry data in 2015.
Abstract Objective: Liver cancer is one of the most common cancers and major cause deaths in China, which accounts for over 50% new cases worldwide. The systematic liver statistics including projection through 2030 could provide valuable information prevention control strategies experience other countries. Methods: burden China 2014 was estimated using 339 registries' data selected from Chinese National Cancer Center (NCC). Incident 22 registries were applied temporal trends 2000 to 2014....
Purpose There are no global screening recommendations for esophageal squamous cell carcinoma (ESCC). Endoscopic has been investigated in areas of high incidence China since the 1970s. This study aimed to evaluate whether an endoscopic and intervention program could reduce mortality caused by ESCC. Methods Residents age 40 69 years were recruited from communities with rates Fourteen villages selected as communities. Ten not geographically adjacent comparison. Participants group screened once...
<h3>Objective:</h3> Breast cancer was the most common and fifth cause of deaths among women in China 2015. The evaluation long-term incidence mortality trends prediction future burden breast could provide valuable information for developing prevention control strategies. <h3>Methods:</h3> 2015 estimated by using qualified data from 368 registries National Central Cancer Registry. Incident cases 22 were used to assess time 2000 A Bayesian age-period-cohort model project 2030....
Objectives To estimate the effectiveness of endoscopic screening programme in reducing incidence and mortality upper gastrointestinal cancer high risks areas China. Design This multicentre population-based cohort study was conducted six China from 2005 to 2015. All permanent residents aged 40 69 years were identified as target subjects. We refer those who invited for collectively group. Of these, we classify undertook screened group but did not accept non-screened Target subjects assigned...
Stage information is crucial for cancer care and essential to improve polices control. However, the distribution of stage at diagnosis common cancers in China not well known. We aimed identify factors associated with five major China.In this multicentre, hospital-based, observational study, we included 23 hospitals 12 provinces from China. focused on lung, stomach, oesophagus, colorectum, female breast, using electronic medical records individual level local hospitals, registration...
Background Gastrointestinal cancers account for a quarter of the global cancer incidence and third cancer-related deaths. We sought to estimate lifetime risks developing dying from gastrointestinal at country, world region, levels in 2020. Methods For this population-based systematic analysis, we obtained estimates mortality rates GLOBOCAN 185 countries, alongside all-cause population data UN. Countries were categorised into quartiles Human Development Index (HDI). The risk was estimated...
Esophageal cancer poses a significant global burden, while its patterns and trends remain to be clarified. The aim of this study is provide an update on the incidence mortality rates esophageal their in China based data from National Cancer Registry.
A milestone goal of the Healthy China Program (2019-2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess progress towards this target, we analyzed updated and 25 specific types in from 2019 2021. We conducted standardized data collection quality control registries across 32 province-level regions China. included 6,410,940 newly diagnosed patients 281 during 2008-2019, with follow-up on vital status available until December estimated age-standardized...
The incidence of gastric cancer (GC) decreased in past decades, which was thought largely attributable to risk factors control, yet China still accounts for 44% global GC burdens. We aimed estimate changing trajectories proportions burdens modifiable from 2000 2050 China, inform future targeted preventive strategies.